PAREXEL International to Present at J.P. Morgan Healthcare Conference
BOSTON, Jan. 4, 2011 - PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the J.P. Morgan Healthcare Conference in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at 8:30 a.m. PT on Thursday, January 13, 2011.
A live webcast of this presentation will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website until April 13, 2011.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 10,170 employees. For more information about PAREXEL International visit www.PAREXEL.com.
SOURCE PAREXEL International Corporation
CONTACT:
Jill Baker,
Corporate Vice President,
Investor Relations,
PAREXEL International,
+1-781-434-4118,
Jill.Baker@PAREXEL.com
Web Site: www.parexel.com
